Nicole Viveiros graduated in Biochemistry by the Faculty of Exact Sciences and Engineering of the University of Madeira (UMa) in 2019. During her final BSc project, she developed laponite nanoformulations for oral administration of alendronate in the treatment of osteoporosis and studied its physicochemical and biological properties using spectroscopic techniques and in vitro models. In 2021, she obtained her MSc degree in Biochemistry from the Faculty of Sciences of the University of Porto (FCUP) and the Institute of Biomedical Sciences Abel Salazar (ICBAS). Her master thesis project was carried out in the Cancer Biology & Epigenetics Group (IPO-Porto), in collaboration with Kymab Ltd, a pharmaceutical company from the Sanofi group established in Cambridge, UK. The main goal was the characterisation of the immune infiltrate of bladder cancer tissue samples through a digital pathology approach and the identification of potentially relevant immuno-oncology biomarkers of the disease. She is proficient in spectroscopic, imaging and molecular biology techniques and holds expertise in the area of digital image analysis. Her main scientific interests include immunology, oncology and biochemistry. 

In 2022, she was awarded with a research fellowship from the Northern Regional Centre of the Portuguese League Against Cancer to work in the Hematopoiesis & Microenvironments group at i3S, in a project that aimed to uncover the role of the heme-exporter FLVCR1 in hepatocellular carcinoma, using in vitro and in vivo models. She is currently working in the Cancer Signaling & Metabolism Group, under the supervision of Prof. Valdemar Máximo.